Evidence map›Paper›PMID 33050601›Full record

ReviewMolecules (Basel, Switzerland)2020

Biomedical Science to Tackle the COVID-19 Pandemic: Current Status and Future Perspectives.

Camilo Zamora-Ledezma, David F Clavijo C, Ernesto Medina, Federico Sinche, Nelson Santiago Vispo, Si Amar Dahoumane, Frank Alexis

Abstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Review
  13. Biomedical Engineering Professional Skills Development: The RADxIEEE open journal of engineering in medicine and biology · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Camilo Zamora-LedezmaSchool of Physical Sciences and Nanotechnology, Yachay Tech University, Urcuquí 100650, Ecuador.ORCID 0000-0002-8704-1539
David F Clavijo CSchool of Biological Sciences and Engineering, Yachay Tech University, Urcuquí 100650, Ecuador.
Ernesto MedinaSchool of Physical Sciences and Nanotechnology, Yachay Tech University, Urcuquí 100650, Ecuador.ORCID 0000-0002-1566-0170
Federico SincheSchool of Biological Sciences and Engineering, Yachay Tech University, Urcuquí 100650, Ecuador.ORCID 0000-0003-1190-2395
Nelson Santiago VispoSchool of Biological Sciences and Engineering, Yachay Tech University, Urcuquí 100650, Ecuador.
Si Amar DahoumaneSchool of Biological Sciences and Engineering, Yachay Tech University, Urcuquí 100650, Ecuador.ORCID 0000-0003-0231-599X
Frank AlexisSchool of Biological Sciences and Engineering, Yachay Tech University, Urcuquí 100650, Ecuador.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The coronavirus infectious disease (COVID-19) pandemic emerged at the end of 2019, and was caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), which has resulted in an unprecedented health and economic crisis worldwide. One key aspect, compared to other recent pandemics, is the level of urgency, which has started a race for finding adequate answers. Solutions for efficient prevention approaches, rapid, reliable, and high throughput diagnostics, monitoring, and safe therapies are needed. Research across the world has been directed to fight against COVID-19. Biomedical science has been presented as a possible area for combating the SARS-CoV-2 virus due to the unique challenges raised by the pandemic, as reported by epidemiologists, immunologists, and medical doctors, including COVID-19's survival, symptoms, protein surface composition, and infection mechanisms. While the current knowledge about the SARS-CoV-2 virus is still limited, various (old and new) biomedical approaches have been developed and tested. Here, we review the current status and future perspectives of biomedical science in the context of COVID-19, including nanotechnology, prevention through vaccine engineering, diagnostic, monitoring, and therapy. This review is aimed at discussing the current impact of biomedical science in healthcare for the management of COVID-19, as well as some challenges to be addressed.

Indexed as

BetacoronavirusBiomedical ResearchCoronavirus InfectionsCOVID-19Disease ManagementHumansPandemicsPneumonia, ViralSARS-CoV-2clinical trialsdiagnosticsnanomedicinepreventiontreatmentvaccines

Identifiers

PMID33050601
PMCPMC7587204

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.